These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 26683239)
61. B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. Dangour AD; Whitehouse PJ; Rafferty K; Mitchell SA; Smith L; Hawkesworth S; Vellas B J Alzheimers Dis; 2010; 22(1):205-24. PubMed ID: 20847412 [TBL] [Abstract][Full Text] [Related]
62. Cardiac risk factors and potential treatments in Alzheimer's disease. Bergmann C; Sano M Neurol Res; 2006 Sep; 28(6):595-604. PubMed ID: 16945210 [TBL] [Abstract][Full Text] [Related]
63. Rivastigmine for Alzheimer's disease. Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562 [TBL] [Abstract][Full Text] [Related]
64. Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease? Part II: Management, prevention and future perspective. Davey DA Neurodegener Dis Manag; 2014; 4(3):261-70. PubMed ID: 25095820 [TBL] [Abstract][Full Text] [Related]
65. An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study. Sen A; Akinola M; Tai XY; Symmonds M; Davis Jones G; Mura S; Galloway J; Hallam A; Chan JYC; Koychev I; Butler C; Geddes J; Van Der Putt R; Thompson S; Manohar SG; Frangou E; Love S; McShane R; Husain M Trials; 2021 Jul; 22(1):508. PubMed ID: 34332638 [TBL] [Abstract][Full Text] [Related]
66. Treatment of epilepsy for people with Alzheimer's disease. Liu J; Wang LN Cochrane Database Syst Rev; 2021 May; 5(5):CD011922. PubMed ID: 33973646 [TBL] [Abstract][Full Text] [Related]
67. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project. Fratiglioni L; Winblad B; von Strauss E Physiol Behav; 2007 Sep; 92(1-2):98-104. PubMed ID: 17588621 [TBL] [Abstract][Full Text] [Related]
68. Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Frisoni GB; Molinuevo JL; Altomare D; Carrera E; Barkhof F; Berkhof J; Delrieu J; Dubois B; Kivipelto M; Nordberg A; Schott JM; van der Flier WM; Vellas B; Jessen F; Scheltens P; Ritchie C Alzheimers Dement; 2020 Oct; 16(10):1457-1468. PubMed ID: 32815289 [TBL] [Abstract][Full Text] [Related]
69. The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease. Lopez Lopez C; Tariot PN; Caputo A; Langbaum JB; Liu F; Riviere ME; Langlois C; Rouzade-Dominguez ML; Zalesak M; Hendrix S; Thomas RG; Viglietta V; Lenz R; Ryan JM; Graf A; Reiman EM Alzheimers Dement (N Y); 2019; 5():216-227. PubMed ID: 31211217 [TBL] [Abstract][Full Text] [Related]
71. Ethical and social implications of using predictive modeling for Alzheimer's disease prevention: a systematic literature review protocol. Angehrn Z; Nordon C; Turner A; Gove D; Karcher H; Keenan A; Neumann M; Sostar J; de Reydet de Vulpillieres F BMJ Open; 2019 Mar; 9(3):e026468. PubMed ID: 30833325 [TBL] [Abstract][Full Text] [Related]